These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 15758559

  • 1. Immeasurably low and non-TRH-stimulatable TSH associated with normal I-123 uptake in two goitrous euthyroid patients: possible existence of other thyroid-hormone regulated thyroid stimulators other than TSH.
    Ikekubo K, Hino M, Saiki Y, Son C, Iwakura T, Kobayashi H, Ishihara T.
    Endocr J; 2005 Feb; 52(1):61-8. PubMed ID: 15758559
    [Abstract] [Full Text] [Related]

  • 2. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG, Hershman JM, Chopra IJ, Levine GA, Pekary E, Geffner DL, Chua Teco GN.
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [Abstract] [Full Text] [Related]

  • 3. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects.
    Kasagi K, Takeuchi R, Misaki T, Kousaka T, Miyamoto S, Iida Y, Konishi J.
    J Endocrinol Invest; 1997 Apr; 20(4):183-8. PubMed ID: 9211123
    [Abstract] [Full Text] [Related]

  • 4. Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease.
    Kashiwai T, Tada H, Asahi K, Hidaka Y, Tamaki H, Iwatani Y, Amino N.
    Endocr J; 1995 Jun; 42(3):405-12. PubMed ID: 7670570
    [Abstract] [Full Text] [Related]

  • 5. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T, Tada H, Watanabe Y, Shimaoka Y, Yagoro A, Hidaka Y, Fujikado T, Amino N.
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [Abstract] [Full Text] [Related]

  • 6. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K, Hidaka A, Nakamura H, Takeuchi R, Misaki T, Iida Y, Konishi J.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on hypophyseo-thyroid function in patients with chronic thyroiditis (author's transl)].
    Miyoshi M.
    Nihon Naibunpi Gakkai Zasshi; 1975 Apr 20; 51(4):193-202. PubMed ID: 808434
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The TRH test in simple goiter].
    Paleari F, Colombo MC, Rovelli F, Capra M.
    Minerva Med; 1982 Dec 15; 73(48):3417-23. PubMed ID: 6817236
    [Abstract] [Full Text] [Related]

  • 12. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.
    Clin Endocrinol (Oxf); 1988 Oct 15; 29(4):357-66. PubMed ID: 2908031
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE.
    J Clin Endocrinol Metab; 1993 Apr 15; 76(4):928-32. PubMed ID: 7682562
    [Abstract] [Full Text] [Related]

  • 14. [Euthyroid goiter with and without functional autonomy in the euthyroid phase: a comparison].
    Hillenhinrichs H, Emrich D.
    Nuklearmedizin; 1998 May 15; 37(3):95-100. PubMed ID: 9604229
    [Abstract] [Full Text] [Related]

  • 15. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    Thyroid; 2006 Dec 15; 16(12):1251-7. PubMed ID: 17199435
    [Abstract] [Full Text] [Related]

  • 16. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM, Schimmel M, Utiger RD.
    J Clin Endocrinol Metab; 1976 Aug 15; 43(2):419-27. PubMed ID: 59733
    [Abstract] [Full Text] [Related]

  • 17. Association of thyroid-stimulating immunoglobulins and thyrotropin-releasing hormone responsiveness in women with euthyroid goiter.
    Smyth PP, Neylan D, O'Donovan DK.
    J Clin Endocrinol Metab; 1983 Nov 15; 57(5):1001-6. PubMed ID: 6137491
    [Abstract] [Full Text] [Related]

  • 18. Evolution of autonomy in idiopathic non-toxic goiter, evaluated by regional suppressibility of 99mTc-uptake and TSH response to TRH.
    Dige-Petersen H, Clemmensen OJ, Hummer L.
    Nuklearmedizin; 1976 Aug 15; 15(4):197-200. PubMed ID: 824625
    [Abstract] [Full Text] [Related]

  • 19. Relationship among thyrotropin (TSH), thyroid stimulating immunoglobulins, and results of triiodothyronine (T3) suppression test in patients with Graves' disease.
    Horimoto M, Nishikawa M, Uno C, Yoshikawa N, Taniguchi N, Inada M.
    Endocrinol Jpn; 1988 Dec 15; 35(6):841-8. PubMed ID: 2471633
    [Abstract] [Full Text] [Related]

  • 20. Low thyrotropin (TSH) levels in goiter. Relationship with scintigraphic findings and other biological parameters.
    Talbot JN, Duron F, Piketty ML, Habert MO, Laforest MD, Milhaud G.
    Thyroidology; 1989 Apr 15; 1(1):39-44. PubMed ID: 2484906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.